Status:

UNKNOWN

A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects

Lead Sponsor:

Biopure Corporation

Conditions:

Wounds and Injuries

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The main purpose of this study is to determine if HBOC-201 is safe and tolerable to trauma subjects, when given to treat the inadequate supply of blood and nutrients to tissues and organs.

Detailed Description

This Phase II study will be a single-center, randomized, single-blind, parallel-group, standard therapy-controlled, variable dose study of HBOC 201 administered to trauma subjects with bleeding or pot...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Male or Female (females not of childbearing potential or negative pregnancy test prior to enrollment)
  • Age ≥ 18 years and ≤ 65 years of age
  • Trauma with bleeding or a potential for bleeding arriving at initial treatment facility directly from scene of injury
  • Subject should be enrolled within four (4) hours of injury
  • Base Deficit (BD) greater than 5.0 and one of the following:
  • Systolic Blood Pressure ≤ 100 mm Hg OR Sustained (≥ 10 minutes) Heart Rate ≥ 100
  • No localized signs of traumatic brain injury and a Glasgow Coma Score of ≥9 with the exception of drug-induced lowered GCS.
  • Informed consent, or independent physician authorization obtained
  • EXCLUSION CRITERIA:
  • Known or suspected Traumatic Brain Injury
  • Non-survivable injury (Falcone Criteria)
  • Traumatic arrest
  • Known prior cardiac arrest (i.e., preceding trauma episode)
  • Known or suspected pregnancy
  • Known allergy to bovine products
  • Prior treatment with blood (subsequent to current trauma)
  • Informed consent or independent physician authorization unable to be obtained
  • Unable to meet protocol or follow-up criteria

Exclusion

    Key Trial Info

    Start Date :

    July 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2008

    Estimated Enrollment :

    53 Patients enrolled

    Trial Details

    Trial ID

    NCT00301483

    Start Date

    July 1 2004

    End Date

    December 1 2008

    Last Update

    March 6 2008

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of Surgery: Johannesburg Hospital

    Johannesburg, Gauteng, South Africa